Thermo Fisher Scientific
In New Deal, Oncocyte Gains Global Market Runway, Thermo Fisher Nabs Steward for Clinical Kits
Premium
Company leaders discussed details about the practical and financial benefits the deal provides both firms this week.
In Brief This Week: Quest Diagnostics, Beckman Coulter, Thermo Fisher Scientific, Diadem, and More
News items for the in vitro diagnostics industry for the week of Jan. 17, 2022.
Thermo Fisher, Oncocyte Ink Development, Comarketing Deal for Cancer IVDs
The companies are working together to bring to market in vitro diagnostic versions of Thermo Fisher's Oncomine Comprehensive Assay Plus and Oncocyte's DetermaIO test.
JP Morgan Healthcare Conference Day 2: Labcorp, Thermo Fisher Scientific, Abbott, Danaher, More
Highlights of the second day included Labcorp's update on its COVID-19 testing trends and Ortho Clinical's perspective on its proposed acquisition by Quidel.Â
Thermo Fisher Scientific, Diazyme Laboratories, Rheonix, Others Obtain FDA Clearances in December
Thermo Fisher got the nod for its Sensititre 18 to 24 hour minimum inhibitory concentration or breakpoint susceptibility system with cefiderocol.
Dec 30, 2021
Top 10 Articles on 360Dx in 2021
Oct 27, 2021
Thermo Fisher Scientific Q3 Revenues up 9 Percent
Sep 22, 2021